Search results
Showing results for
The Medicine Quality Research Group has published a new Medical Product Quality Report focussing on increasing issues around substandard and falsified (SF) COVID-19 vaccines. With the implementation of the key innovations of COVID-19 vaccines, there have been growing numbers of reports of SF vaccines in the public domain. Given the vital role they will play in ending the pandemic and protecting the global population but severe issues with equitable access, SF vaccines are highly likely to be a growing problem.
Chris Paton
BMBS BMedSci MBA DPhil FBCS Chris Paton - Honorary Visiting Scientist
Evelyne Kestelyn
Evelyne Kestelyn - Head of the Clinical Trials Unit
Ashata Dahal
Ashata Dahal - Public Engagement Manager (OUCRU Nepal)/ DPhil candidate (University of Oxford)
Suchita Shrestha
Suchita Shrestha - Head of the Clinical Trials Unit, OUCRU Nepal
Gisela Robles Aguilar
Gisela Robles Aguilar - Global Burden of Disease Researcher
Rachel Hounsell
Rachel Hounsell - Senior Researcher and Teaching Fellow
Proochista Ariana
- MSc IHTM Executive Team
- MSc IHTM Lecturers
- MSc IHTM advisory committee
- MSc MGH Lecturers
- Principal Investigators
- Research Scientists
Proochista Ariana - Associate Professor
Wirichada Pan-ngum
Wirichada Pan-ngum - Associate Professor
Kevin Marsh
Kevin Marsh - Professor of Tropical Medicine